Is epkinly a biologic?

Is Epkinly (epcoritamab) considered a biologic?

Yes. Epkinly (epcoritamab) is a biologic medicine because it is a monoclonal antibody-based therapy. Monoclonal antibodies are made using biological processes rather than traditional small-molecule chemical synthesis, which is why they fall under the biologics category.

Why people may be confused: “biologic” vs “biosimilar” vs “biologic-like”

Epkinly is not described as a biosimilar; it is the original biologic medicine (a specific monoclonal antibody product). Biosimilars are separate versions that are highly similar to a licensed reference biologic. Epkinly’s classification is biologic, not biosimilar.

What category it fits in (practical context)

In practical terms, Epkinly is regulated and prescribed as an antibody-based biologic cancer therapy (not as a typical pill small molecule). That matters for how it’s manufactured, handled, and covered compared with non-biologic drugs.

Source

[1] https://www.drugpatentwatch.com/